Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H15NO2.ClH |
Molecular Weight | 229.703 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC2=C(CCN[C@@H]2C)C=C1O
InChI
InChIKey=PZZVNEZKNWRZEG-OGFXRTJISA-N
InChI=1S/C11H15NO2.ClH/c1-7-9-6-11(14-2)10(13)5-8(9)3-4-12-7;/h5-7,12-13H,3-4H2,1-2H3;1H/t7-;/m1./s1
Molecular Formula | C11H15NO2 |
Molecular Weight | 193.2423 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Salsoline is a metabolite of dopamine and is highly prevalent in the urine and cerebrospinal fluid of alcoholics at the time of intoxication and for several days after. Salsoline and related compounds bind to the Type A Mono-amine Oxidase inducing neuronal cell death. At one time salsoline was thought to be a biomarker for Parkinson's disease. However, it was later shown that treatment regimes result in an increased endogenous concentration of salsoline and related compounds.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P21397 Gene ID: 4128.0 Gene Symbol: MAOA Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2296014 |
77.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines. | 2002 May |
|
Tetrahydroisoquinoline derivatives of enkephalins: synthesis and properties. | 2002 May 15 |
|
Cell death in Parkinson's disease. | 2002 Sep |
|
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. | 2002 Sep-Oct |
|
Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective. | 2003 Jul |
|
Tetrahydroisoquinoline and beta-carboline alkaloids from Haloxylon articulatum (Cav.) Bunge (Chenopodiaceae). | 2003 Jul-Aug |
|
N-methyl-norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioural changes. | 2003 Mar |
|
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease. | 2004 Apr |
|
Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection. | 2008 Dec |
|
A new microdialysis-electrochemical device for in vivo simultaneous determination of acetylcholine and choline in rat brain treated with N-methyl-(R)-salsolinol. | 2009 Aug 15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2296014
highly purified Monoamine oxidase A and B were tested with a series of isoquinolines. Stereoselective competitive inhibition of MAO-A was observed for the R enantiomer of salsoline (Ki = 77 micro-M). Salsoline did not show meaningful inhibition of MAO-B.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 22:12:09 GMT 2023
by
admin
on
Fri Dec 15 22:12:09 GMT 2023
|
Record UNII |
JYW06894PT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
JYW06894PT
Created by
admin on Fri Dec 15 22:12:10 GMT 2023 , Edited by admin on Fri Dec 15 22:12:10 GMT 2023
|
PRIMARY | |||
|
51424-33-0
Created by
admin on Fri Dec 15 22:12:10 GMT 2023 , Edited by admin on Fri Dec 15 22:12:10 GMT 2023
|
PRIMARY | |||
|
DTXSID20965743
Created by
admin on Fri Dec 15 22:12:10 GMT 2023 , Edited by admin on Fri Dec 15 22:12:10 GMT 2023
|
PRIMARY | |||
|
m9748
Created by
admin on Fri Dec 15 22:12:10 GMT 2023 , Edited by admin on Fri Dec 15 22:12:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
40009
Created by
admin on Fri Dec 15 22:12:10 GMT 2023 , Edited by admin on Fri Dec 15 22:12:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |